XML 27 R55.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value Measurements - Changes in fair value of Level 3 liabilities (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2020
Business Combination Contingent Consideration Liability [Roll Forward]      
Acquisition-related accrued interest $ (75) $ 0 $ (200)
Level 3      
Business Combination Contingent Consideration Liability [Roll Forward]      
Acquisition-related accrued interest     (200)
Balance at March 31, 2020 $ (7,753)   (7,753)
Osprey Biotechnics, Inc. ("Osprey") | Level 3      
Business Combination Contingent Consideration Liability [Roll Forward]      
Acquisition     $ (7,553)